Rep. Stava-Murray supports HB4327 to review Illinois 340B Drug Discount Program

Rep. Anne Stava-Murray (D-81st) cast a Yes vote on HB4327, legislation mandating an audit of Illinois 340B Drug Discount Program entities, during the 104th General Assembly on May 31, 2026. The Illinois House approved the bill with a 106-8 vote.

The bill's official description states: "AUDITOR GENERAL-340B AUDIT."

Below is a summary derived from the bill text, intended to clarify the measure's requirements.

The bill instructs the Illinois auditor general to conduct a thorough audit, as soon as practicable after the measure takes effect, of the activities of 340B covered entities participating in the federal 340B Drug Discount Program. Areas for review include profits tied to 340B drugs, expenditures related to third-party administrators, payments involving pharmacy benefit managers and contract pharmacies, ownership of drugs at contract pharmacy locations, typical markups on 340B-priced drugs, and how frequently eligible patients directly receive discounts. The auditor general is required to deliver findings and recommendations to the General Assembly.

The official action on HB4327 was 'Senate Committee Amendment No. 1 House Concurs'.

Stava-Murray earned a BA from Dartmouth College in 2008.

A Democrat, Stava-Murray began serving in the Illinois State House in 2019, representing the 81st House District after succeeding David S. Olsen.

Legislation in Illinois progresses through a multi-step process that starts with introduction in either chamber, followed by committee consideration, debates, and votes in both the House and Senate before advancing to the governor for a decision. The General Assembly convenes every two years, reviewing thousands of bills each session, with only a portion advancing to become law.